The author indicated that the drug Zoladex would no longer be reimbursed by Health Insurance starting in December as part of breast cancer treatment. He specified that this decision had been requested by the manufacturer, AstraZeneca. https://t.co/cR6exMdljw #CancerDuSein #Zoladex #AstraZeneca #FR (translated)
